Stock Market Reviews

INGN (Inogen, Inc.) News

Get the latest news, insights, and market updates on INGN (Inogen, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Earnings Preview: RxSight, Inc. (RXST) Q4 Earnings Expected to Decline
  RxSight (RXST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  Feb 18, 2026 - $INGN
• Inogen (INGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
  Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  Feb 17, 2026 - $INGN
• Inogen (INGN) Soars 6.6%: Is Further Upside Left in the Stock?
  Inogen (INGN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
  Feb 12, 2026 - $INGN
• Pleasing Signs As A Number Of Insiders Buy Inogen Stock
  It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
  Feb 10, 2026 - $INGN
• Inogen (INGN) Loses 10.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
  The heavy selling pressure might have exhausted for Inogen (INGN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
  Feb 10, 2026 - $INGN
• Idexx Laboratories (IDXX) Beats Q4 Earnings and Revenue Estimates
  Idexx (IDXX) delivered earnings and revenue surprises of +5.17% and +1.86%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
  Feb 2, 2026 - $INGN
• Here's Why You Should Add Inogen Stock to Your Portfolio Now
  INGN looks poised as Q3 revenue rises 4%, POC demand grows and valuation is low, despite seasonal softness.
  Feb 2, 2026 - $INGN
• Inogen Announces Preliminary Revenue Results for Fourth Quarter and Full-Year 2025
  GOLETA, Calif., January 12, 2026--Inogen to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
  Jan 12, 2026 - $INGN
• INGN Stock Gains Post Latest Launch to Expand Respiratory Care Suite
  Inogen launches Aurora CPAP masks to expand its respiratory care suite and enter the growing sleep apnea market.
  Jan 8, 2026 - $INGN
• Inogen Announces the Launch of Aurora CPAP Masks for Obstructive Sleep Apnea in the United States
  GOLETA, Calif., January 07, 2026--Inogen Announces the Launch of Aurora CPAP Masks for Obstructive Sleep Apnea in the United States.
  Jan 7, 2026 - $INGN